参考文献/References:
[1]Shen YW,Shih YH,Fuh LJ,et al.Oral Submucous Fibrosis: A Review on Biomarkers,Pathogenic Mechanisms,and Treatments[J].Int J Mol Sci,2020,21(19):7231.[2]Dionne KR,Warnakulasuriya S,Zain RB,et al.Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory[J].Int J Cancer,2015,136(3):503-515.[3]Chole RH,Gondivkar SM,Gadbail AR,et al.Review of drug treatment of oral submucous fibrosis[J].Oral Oncol,2012,48(5):393-398.[4]Tilakaratne WM,Ekanayaka RP,Warnakulasuriya S.Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2016,122(2):178-191.[5]Chattopadhyay A,Ray JG.Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis[J].J Environ Pathol Toxicol Oncol,2016,35(3):193-205.[6]Zhang SS,Li WH,Gao YJ,et al.Betel-quid and oral submucous fibrosis: a cross-sectional study in Hunan province,China[J].J Oral Pathol Med,2012,41(10):748-754.[7]Cai X,Yao Z,Liu G,et al.Oral submucous fibrosis: A clinicopathological study of 674 cases in China[J].J Oral Pathol Med,2019,48(4):321-325.[8]Tilakaratne WM,Ekanayaka RP,Herath M,et al.Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2016,122(2):224-231.[9]Shah PH,Venkatesh R,More CB,et al.Comparison of Therapeutic Efficacy of Placental Extract with Dexamethasone and Hyaluronic Acid with Dexamethasone for Oral Submucous Fibrosis-A Retrospective Analysis[J].J Clin Diagn Res,2016,10(10):C63-C66.[10]Johny J,Bhagvandas SC,Mohan SP,et al.Comparison of Efficacy of Lycopene and Lycopene-Hyaluronidase Combination in the Treatment of Oral Submucous Fibrosis[J].J Pharm Bioallied Sci,2019,11(Suppl 2):S260-S264.[11]James L,Shetty A,Rishi D,et al.Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study[J].J Int Oral Health,2015,7(8):82-85.[12]Nagaraj T,Santosh HN.Estimation of serum hepcidin in oral submucous fibrosis before and after supplementation with oral iron: A randomized control clinical trial[J].J Oral Maxillofac Pathol,2018,22(3):303-306.[13]Guruprasad R,Nair PP,Singh M,et al.Serum vitamin c and iron levels in oral submucous fibrosis[J].Indian J Dent,2014,5(2):81-85.[14]Fang CY,Yu CC,Liao YW,et al.LncRNA LINC00974 activates TGF-beta/Smad signaling to promote oral fibrogenesis[J].J Oral Pathol Med,2019,48(2):151-158.[15]Liao YW,Yu CC,Hsieh PL,et al.miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2[J].J Cell Mol Med,2018,22(9):4130-4138.[16]Gupta AK,Tulsyan S,Thakur N,et al.Chemistry,metabolism and pharmacology of carcinogenic alkaloids present in areca nut and factors affecting their concentration[J].Regul Toxicol Pharmacol,2020,110:104548.[17]Deng YT,Chen HM,Cheng SJ,et al.Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin[J].Oral Oncol,2009,45(9):e99-e105.[18]Chang JZ,Yang WH,Deng YT,et al.Thrombin-stimulated connective tissue growth factor (CTGF/CCN2) production in human buccal mucosal fibroblasts: Inhibition by epigallocatechin-3-gallate[J].Head Neck,2012,34(8):1089-1094.[19]Moutasim KA,Jenei V,Sapienza K,et al.Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis[J].J Pathol,2011,223(3):366-377.[20]Tilakaratne WM,Klinikowski MF,Saku T,et al.Oral submucous fibrosis: review on aetiology and pathogenesis[J].Oral Oncol,2006,42(6):561-568.